Clarus Ventures Iii, Llc - Net Worth and Insider Trading

Clarus Ventures Iii, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Clarus Ventures Iii, Llc owns 4 companies in total, including Gritstone Bio Inc (GRTSQ) , Entasis Therapeutics Holdings Inc (ETTX) , and Forty Seven Inc (FTSV) among others .

Click here to see the complete history of Clarus Ventures Iii, Llc’s form 4 insider trades.

Insider Ownership Summary of Clarus Ventures Iii, Llc

Ticker	Comapny	Transaction Date	Type of Owner
GRTSQ	Gritstone Bio Inc	2018-09-27	10 percent owner
ETTX	Entasis Therapeutics Holdings Inc	2018-09-25	10 percent owner
FTSV	Forty Seven Inc	2018-07-02	10 percent owner
		2018-06-20	10 percent owner

Clarus Ventures Iii, Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Clarus Ventures Iii, Llc Ownership Network

Ownership Network List of Clarus Ventures Iii, Llc

No Data

Ownership Network Relation of Clarus Ventures Iii, Llc

Clarus Ventures Iii, Llc Owned Company Details

What does Gritstone Bio Inc do?

Who are the key executives at Gritstone Bio Inc?

Clarus Ventures Iii, Llc is the 10 percent owner of Gritstone Bio Inc. Other key executives at Gritstone Bio Inc include director & President and CEO Andrew R Allen , See Remarks Matthew Hawryluk , and See Remarks Karin Jooss .

Gritstone Bio Inc (GRTSQ) Insider Trades Summary

Over the past 18 months, Clarus Ventures Iii, Llc made no insider transaction in Gritstone Bio Inc (GRTSQ). Other recent insider transactions involving Gritstone Bio Inc (GRTSQ) include a net sale of 1,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Karin Jooss .

In summary, during the past 3 months, insiders sold 0 shares of Gritstone Bio Inc (GRTSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 74,769 shares of Gritstone Bio Inc (GRTSQ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 62,769 shares.

Gritstone Bio Inc (GRTSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gritstone Bio Inc Insider Transactions

No Available Data

What does Entasis Therapeutics Holdings Inc do?

Who are the key executives at Entasis Therapeutics Holdings Inc?

Clarus Ventures Iii, Llc is the 10 percent owner of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Medical Officer David Altarac .

Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entasis Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Forty Seven Inc do?

Who are the key executives at Forty Seven Inc?

Clarus Ventures Iii, Llc is the 10 percent owner of Forty Seven Inc. Other key executives at Forty Seven Inc include Chief Financial Officer Ann D Rhoads , 10 percent owner Lightspeed General Partner X, L.p. , and 10 percent owner Lightspeed Ultimate General Partner X, Ltd. .

Forty Seven Inc (FTSV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Forty Seven Inc (FTSV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forty Seven Inc (FTSV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Forty Seven Inc (FTSV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Forty Seven Inc Insider Transactions

No Available Data

What does Avrobio Inc do?

Who are the key executives at Avrobio Inc?

Clarus Ventures Iii, Llc is the 10 percent owner of Avrobio Inc. Other key executives at Avrobio Inc include Chief Technology Officer Azadeh Golipour , Chief Medical Officer Essra Ridha , and Chief Scientific Officer Christopher Mason .

Avrobio Inc (AVRO) Insider Trades Summary

Over the past 18 months, Clarus Ventures Iii, Llc made no insider transaction in Avrobio Inc (AVRO). Other recent insider transactions involving Avrobio Inc (AVRO) include a net purchase of 766,635 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Avrobio Inc (AVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avrobio Inc (AVRO) were sold and 63,886 shares were bought by its insiders, resulting in a net purchase of 63,886 shares.

Avrobio Inc (AVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avrobio Inc Insider Transactions

No Available Data

Clarus Ventures Iii, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Clarus Ventures Iii, Llc. You might contact Clarus Ventures Iii, Llc via mailing address: 101 Main Street, Suite 1210, Cambridge Ma 02142.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.